Amyris, Inc. (Nasdaq: AMRS), today presented clinical data showcasing the superiority of its natural sugarcane squalane (marketed and sold as Neossance Squalane) as a carrier of CBD versus other oils. In order for CBD to be effective in topical applications, skin penetration is a key factor
March 6, 2020
· 5 min read